Literature DB >> 19628748

ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.

Jianfeng Shen1, Yalan Wu, Jing-Ying Xu, Jingfa Zhang, Stephen H Sinclair, Myron Yanoff, Guoxu Xu, Weiye Li, Guo-Tong Xu.   

Abstract

PURPOSE: To characterize the neuroprotective mechanisms of erythropoietin (EPO) against the stress of glyoxal-advanced glycation end products (AGEs) in retinal neuronal cells.
METHODS: Rat retinal organ culture, primary retinal neuron culture, and retinal cell line (R28 cell) culture under glyoxal-AGEs insult were used as in vitro models. Exogenous EPO was applied to these models. Retinal neuronal cell death was assessed by TUNEL, ethidium bromide/acridine orange staining, and cell viability assay. R28 cell proliferation was evaluated by BrdU incorporation and propidium iodide staining. Real-time RT-PCR and Western blot analysis were used to detect Bcl-xL, Bcl-2, Bax, BAD, and products of extracellular signal regulated kinase (ERK) and Akt pathways. Specific inhibitors and plasmids were used to pinpoint the roles of ERK and Akt pathways. Results. EPO protected the retinal cells from glyoxal-AGE-induced injury in a time- and dose-dependent fashion. The protective function of EPO was proved to be antiapoptotic, not pro-cell proliferative. Glyoxal upregulated Bax expression but suppressed Bcl-xL expression and BAD phosphorylation. In contrast, EPO enhanced BAD phosphorylation and Bcl-xL expression but downregulated Bax. The regulation of these apoptosis-related proteins by EPO was through ERK and Akt pathways.
CONCLUSIONS: These data demonstrate that exogenous EPO significantly attenuates the retinal neuronal cell death induced by glyoxal-AGEs by promoting antiapoptotic and suppressing apoptotic proteins. EPO/EPO receptor signaling through ERK and Akt pathways is pivotal in EPO neuroprotective mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628748     DOI: 10.1167/iovs.09-3544

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

Review 1.  Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

Authors:  Cristina Hernández; Rafael Simó
Journal:  Endocrine       Date:  2011-12-14       Impact factor: 3.633

2.  Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling.

Authors:  Erica A Dale; Irawan Satriotomo; Gordon S Mitchell
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

Review 3.  Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function.

Authors:  E A Dale; F Ben Mabrouk; G S Mitchell
Journal:  Physiology (Bethesda)       Date:  2014-01

4.  Chapter 6 - Restoring Vision to the Blind: Neuroprotection.

Authors: 
Journal:  Transl Vis Sci Technol       Date:  2014-12-30       Impact factor: 3.283

5.  WISP1 (CCN4) autoregulates its expression and nuclear trafficking of β-catenin during oxidant stress with limited effects upon neuronal autophagy.

Authors:  Shaohui Wang; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2012-05       Impact factor: 1.990

Review 6.  Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

7.  Safety and efficacy of intravitreal injection of recombinant erythropoietin for protection of photoreceptor cells in a rat model of retinal detachment.

Authors:  Z Xie; F Chen; X Wu; C Zhuang; J Zhu; J Wang; H Ji; Y Wang; X Hua
Journal:  Eye (Lond)       Date:  2011-10-21       Impact factor: 3.775

8.  Carbon monoxide treatment reduces microglial activation in the ischemic rat retina.

Authors:  Felix Ulbrich; Ulrich Goebel; Daniel Böhringer; Petar Charalambous; Wolf Alexander Lagrèze; Julia Biermann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-21       Impact factor: 3.117

9.  WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1.

Authors:  Shaohui Wang; Zhao Zhong Chong; Yan Chen Shang; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2013-02       Impact factor: 1.990

Review 10.  Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.

Authors:  Kenneth Maiese
Journal:  Expert Rev Clin Pharmacol       Date:  2020-01-03       Impact factor: 5.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.